Bryant D. Lim

Overview

Bryant D. Lim received $2M in total compensation, including $359K in salary, at Prelude Therapeutics in 2023. Bryant Lim also received an average of $729K at Idera Pharmaceuticals from 2018 to 2020.

Source: SEC filings on April 26, 2024, April 28, 2021, and April 6, 2020.

Related executives

We found 20 more executives who work or worked at Prelude Therapeutics and Idera Pharmaceuticals.

Krishna Vaddi

Prelude Therapeutics

Chief Executive Officer

Jane Huang

Prelude Therapeutics

Chief Medical Officer

Peggy Scherle

Prelude Therapeutics

Chief Scientific Officer

Brian Piper

Prelude Therapeutics

Chief Financial Officer

Andrew Combs

Prelude Therapeutics

EVP and Head of Chemistry

Vincent Milano

Idera Pharmaceuticals

Chief Executive Officer

R Fletcher

Idera Pharmaceuticals

Senior Vice President, Business Development and Strategy

John Kirby

Idera Pharmaceuticals

Chief Financial Officer

News

You may also like